[Clinical value of multiparameteric quantitative ultrasound for assessing high-risk steatohepatitis]

Zhonghua Gan Zang Bing Za Zhi. 2024 Sep 20;32(9):820-827. doi: 10.3760/cma.j.cn501113-20240320-00146.
[Article in Chinese]

Abstract

Objective: To investigate the clinical value of multiparameteric quantitative ultrasound combined with a non-invasive prediction model for assessing high-risk steatohepatitis. Methods: One hundred and ninety-four cases with metabolic-associated fatty liver disease (MAFLD) who underwent liver biopsy in Huashan Hospital, Fudan University, from June 2021 to September 2022 were selected. Shear wave elastography (SWE), shear wave dispersion (SWD) imaging, and attenuation imaging (ATI) examinations were conducted in all patients before biopsy. High-risk steatohepatitis was defined as a total activity score of ≥4 in patients with steatohepatitis, hepatocellular ballooning, and liver lobular inflammation based on pathological hepatic steatosis, inflammatory activity, and fibrosis scoring system (SAF), and fibrosis stage≥F2. Binary logistic regression analysis was used to identify the factors influencing high-risk steatohepatitis. A predictive model for diagnosing high-risk steatohepatitis was constructed using R language. The DeLong test was used to compare the area under the curve between groups. Measurement data was compared between groups using the t-test or rank-sum test, and count data were compared between groups using the χ2 test. Results: There were 46 cases (23.7%) with high-risk steatohepatitis. The quantitative ultrasound parameters included elastic modulus (OR=2.958, 95%CI: 1.889-4.883, P<0.001), dispersion coefficient (OR=1.786, 95%CI: 1.424-2.292, P<0.001) and attenuation coefficient (OR=42.642, 95%CI: 3.463-640.451, P=0.004). Serological indexes of fasting blood glucose (OR=1.196, 95%CI: 1.048-1.392, P=0.011), alanine aminotransferase (OR=1.012, 95%CI: 1.006-1.019, P<0.001), aspartate aminotransferase (OR=1.027, 95%CI: 1.014-1.042, P<0.001), γ-glutamyl transferase (OR=1.008, 95%CI: 1.001-1.017, P=0.041) and HDL cholesterol (OR=0.087, 95%CI: 0.016-0.404, P=0.003) were the factors influencing its progression. The AUCs of elastic modulus, dispersion coefficient, attenuation coefficient, multiparametric ultrasound model, serological index model, and ultrasound combined with serology model for the diagnosis of high-risk steatohepatitis were 0.764, 0.758, 0.634, 0.786, 0.773 and 0.825, respectively. The results of the DeLong test showed that the ultrasound combined with the serological model was significantly better than the serological index model and the elastic modulus, dispersion coefficient, and attenuation coefficient alone (P=0.024, 0.027, 0.038 and <0.001). Conclusion: The combination of multiparametric quantitative ultrasound is helpful for the non-invasive diagnosis of high-risk steatohepatitis and possesses great clinical significance.

目的: 探讨多参数定量超声组合的预测模型无创评估高风险脂肪性肝炎的临床价值。 方法: 选取2021年6月至2022年9月于复旦大学附属华山医院就诊并进行肝活检的代谢相关脂肪性肝病(MAFLD)患者194例,所有患者肝活检前均行剪切波弹性成像(SWE)、剪切波频散成像(SWD)和衰减成像(ATI)检查。以病理肝脂肪变性、炎症活动度、纤维化评分系统(SAF)为标准,高风险脂肪性肝炎定义为在脂肪性肝炎患者中脂肪变性、肝细胞气球样变及肝脏小叶炎症三者的总活动评分≥4,且纤维化分期≥F2。二元logistic回归分析高风险脂肪性肝炎的影响因素,并依此使用R语言构建诊断高风险脂肪性肝炎的预测模型,DeLong检验进行组间曲线下面积比较。计量资料用t检验或秩和检验进行组间比较,计数资料用χ2检验进行组间比较。 结果: 高风险脂肪性肝炎患者46例(23.7%),定量超声参数包括弹性模量(OR=2.958,95%CI:1.889~4.883,P<0.001)、频散系数(OR=1.786,95%CI:1.424~2.292,P<0.001)和衰减系数(OR=42.642,95%CI:3.463~640.451,P=0.004);血清学指标空腹血糖(OR=1.196,95%CI:1.048~1.392,P=0.011)、丙氨酸转氨酶(OR=1.012,95%CI:1.006~1.019,P<0.001)、天冬氨酸转氨酶(OR=1.027,95%CI:1.014~1.042,P<0.001)、γ-谷氨酰转移酶(OR=1.008,95%CI:1.001~1.017,P=0.041)和高密度脂蛋白胆固醇(OR=0.087,95%CI:0.016~0.404,P=0.003)是其进展的影响因素。弹性模量、频散系数、衰减系数、多参数超声模型、血清学指标模型和超声结合血清学模型诊断高风险脂肪性肝炎的曲线下面积分别为0.764、0.758、0.634、0.786、0.773和0.825。DeLong检验结果显示超声结合血清学模型明显优于血清学指标模型和单独的弹性模量、频散系数、衰减系数(P值分别为0.024和0.027、0.038、<0.001)。 结论: 多参数定量超声的组合有助于无创诊断高风险脂肪性肝炎,具有较大的临床意义。.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Biopsy
  • Elasticity Imaging Techniques* / methods
  • Fatty Liver* / diagnosis
  • Fatty Liver* / diagnostic imaging
  • Female
  • Humans
  • Liver Cirrhosis / diagnostic imaging
  • Liver* / diagnostic imaging
  • Liver* / pathology
  • Logistic Models
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / diagnostic imaging
  • Risk Factors
  • Ultrasonography* / methods